Bimatoprost NDC 42571-128

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-128Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0128Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-128-21	42571012821	1 BOTTLE in 1 CARTON (42571-128-21) / 5 mL in 1 BOTTLEMarketed from Mar 15, 2021
42571-128-28	42571012828	1 BOTTLE in 1 CARTON (42571-128-28) / 7.5 mL in 1 BOTTLEMarketed from Mar 15, 2021
42571-128-35	42571012835	1 BOTTLE in 1 CARTON (42571-128-35) / 2.5 mL in 1 BOTTLEMarketed from Mar 15, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bimatoprost
Generic name (nonproprietary): bimatoprost
Active ingredients: Bimatoprost — .3 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Micro Labs Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202505
Marketing start: Mar 15, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 42571-128_22ffbe26-763a-a793-e063-6394a90a6027SPL ID 22ffbe26-763a-a793-e063-6394a90a6027SPL set ID 8c021e8a-2938-42a7-a17e-2f7f97256344RxCUI 308739UNII QXS94885MZUPC 0342571128210, 0342571128289
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571012821 followed by a unit qualifier and the quantity

Package 42571-0128-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 26, 2024.

Indications (excerpt from the label)

Bimatoprost ophthalmic solution 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Bimatoprost ophthalmic solution 0.03% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202505

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202505
Product	Strength	Form · route	Labeler	Product NDC
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3612